{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:00:45Z","timestamp":1793750445640,"version":"4.6.1"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007136","name":"Secretar\u00eda de Estado de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["BFU2012- 33594"],"award-info":[{"award-number":["BFU2012- 33594"]}],"id":[{"id":"10.13039\/501100007136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007136","name":"Secretar\u00eda de Estado de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["BFU2013-47384-R"],"award-info":[{"award-number":["BFU2013-47384-R"]}],"id":[{"id":"10.13039\/501100007136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"Consejer\u00eda de Sanidad, Comunidad de Madrid","doi-asserted-by":"publisher","award":["S2010\/BMD-2423"],"award-info":[{"award-number":["S2010\/BMD-2423"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s40620-016-0278-5","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T07:04:01Z","timestamp":1457420641000},"page":"603-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Lipotoxicity as a trigger factor of renal disease"],"prefix":"10.1093","volume":"29","author":[{"given":"Adriana","family":"Izquierdo-Lahuerta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Medina-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"issue":"3","key":"278_CR1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","volume":"1801","author":"S Virtue","year":"2010","unstructured":"Virtue S, Vidal-Puig A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome\u2013an allostatic perspective. Biochim Biophys Acta 1801(3):338\u2013349","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"278_CR2","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1371\/journal.pgen.0030064","volume":"3","author":"G Medina-Gomez","year":"2007","unstructured":"Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS, Lopez M, Seppanen-Laakso T, Ashcroft FM, Oresic M, Vidal-Puig A (2007) PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3(4):e64. doi: 10.1371\/journal.pgen.0030064 (06-PLGE-RA-0397R3 [pii])","journal-title":"PLoS Genet"},{"issue":"10A","key":"278_CR3","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1017\/S1368980007000614","volume":"10","author":"G Medina-Gomez","year":"2007","unstructured":"Medina-Gomez G, Gray S, Vidal-Puig A (2007) Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). Public Health Nutr 10(10A):1132\u20131137. doi: 10.1017\/S1368980007000614 (S1368980007000614 [pii])","journal-title":"Public Health Nutr"},{"issue":"5","key":"278_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1242\/dmm.009266","volume":"5","author":"C Martinez-Garcia","year":"2012","unstructured":"Martinez-Garcia C, Izquierdo A, Velagapudi V, Vivas Y, Velasco I, Campbell M, Burling K, Cava F, Ros M, Oresic M, Vidal-Puig A, Medina-Gomez G (2012) Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. Dis Model Mech 5(5):636\u2013648. doi: 10.1242\/dmm.009266","journal-title":"Dis Model Mech"},{"issue":"8311","key":"278_CR5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","volume":"2","author":"JF Moorhead","year":"1982","unstructured":"Moorhead JF, Chan MK, El-Nahas M, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2(8311):1309\u20131311","journal-title":"Lancet"},{"issue":"2","key":"278_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1053\/j.ajkd.2011.07.024","volume":"59","author":"SS Chugh","year":"2012","unstructured":"Chugh SS, Clement LC, Mace C (2012) New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis 59(2):284\u2013292. doi: 10.1053\/j.ajkd.2011.07.024 (S0272-6386(11)01306-0 [pii])","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"278_CR7","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1097\/01.ASN.0000141963.04540.3E","volume":"15","author":"CK Abrass","year":"2004","unstructured":"Abrass CK (2004) Overview: obesity: what does it have to do with kidney disease? J Am Soc Nephrol 15(11):2768\u20132772. doi: 10.1097\/01.ASN.0000141963.04540.3E","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"278_CR8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1681\/ASN.V114669","volume":"11","author":"JA Joles","year":"2000","unstructured":"Joles JA, Kunter U, Janssen U, Kriz W, Rabelink TJ, Koomans HA, Floege J (2000) Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 11(4):669\u2013683","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"278_CR9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11892-005-0064-6","volume":"5","author":"SS Shankar","year":"2005","unstructured":"Shankar SS, Steinberg HO (2005) FFAs: do they play a role in vascular disease in the insulin resistance syndrome? Curr Diab Rep 5(1):30\u201335","journal-title":"Curr Diab Rep"},{"issue":"4","key":"278_CR10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MNH.0b013e32833aa4ac","volume":"19","author":"IA Bobulescu","year":"2010","unstructured":"Bobulescu IA (2010) Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens 19(4):393\u2013402","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"278_CR11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ndt\/16.2.215","volume":"16","author":"J Iglesias","year":"2001","unstructured":"Iglesias J, Levine JS (2001) Albuminuria and renal injury\u2014beware of proteins bearing gifts. Nephrol Dial Transpl 16(2):215\u2013218","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"278_CR12","doi-asserted-by":"crossref","first-page":"F640","DOI":"10.1152\/ajprenal.00001.2002","volume":"283","author":"ME Thomas","year":"2002","unstructured":"Thomas ME, Harris KP, Walls J, Furness PN, Brunskill NJ (2002) Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria. Am J Physiol Renal Physiol 283(4):F640\u2013F647","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"278_CR13","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1371\/journal.pbio.0060237","volume":"6","author":"S Virtue","year":"2008","unstructured":"Virtue S, Vidal-Puig A (2008) It\u2019s not how fat you are, it\u2019s what you do with it that counts. PLoS Biol 6(9):e237. doi: 10.1371\/journal.pbio.0060237 (08-PLBI-E-1259 [pii])","journal-title":"PLoS Biol"},{"issue":"3","key":"278_CR14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/01.ATV.21.3.407","volume":"21","author":"JM Bard","year":"2001","unstructured":"Bard JM, Charles MA, Juhan-Vague I, Vague P, Andre P, Safar M, Fruchart JC, Eschwege E (2001) Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study. Arterioscler Thromb Vasc Biol 21(3):407\u2013414","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"278_CR15","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1210\/jc.2003-032056","volume":"89","author":"JS Cohn","year":"2004","unstructured":"Cohn JS, Patterson BW, Uffelman KD, Davignon J, Steiner G (2004) Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity. J Clin Endocrinol Metab 89(8):3949\u20133955","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"278_CR16","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","volume":"369","author":"A Parsa","year":"2013","unstructured":"Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ, Investigators AS, Investigators CS (2013) APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 369(23):2183\u20132196. doi: 10.1056\/NEJMoa1310345","journal-title":"N Engl J Med"},{"issue":"5993","key":"278_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329(5993):841\u2013845. doi: 10.1126\/science.1193032","journal-title":"Science"},{"issue":"7","key":"278_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneph.2014.87","volume":"10","author":"A Fornoni","year":"2014","unstructured":"Fornoni A, Merscher S, Kopp JB (2014) Lipid biology of the podocyte\u2013new perspectives offer new opportunities. Nat Rev Nephrol 10(7):379\u2013388. doi: 10.1038\/nrneph.2014.87","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"278_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1523-1755.2001.00469.x","volume":"59","author":"MC Iglesias-De La Cruz","year":"2001","unstructured":"Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, Rodriguez-Puyol M, Ziyadeh FN, Rodriguez-Puyol D (2001) Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 59(1):87\u201395","journal-title":"Kidney Int"},{"issue":"10","key":"278_CR20","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1681\/ASN.2007010089","volume":"18","author":"S Kume","year":"2007","unstructured":"Kume S, Uzu T, Araki S, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Kubota N, Terauchi Y, Kadowaki T, Haneda M, Kashiwagi A, Koya D (2007) Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol 18(10):2715\u20132723","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"278_CR21","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1172\/JCI23962","volume":"115","author":"G Jiang","year":"2005","unstructured":"Jiang G, Li Z, Liu F, Ellsworth K, Dallas-Yang Q, Wu M, Ronan J, Esau C, Murphy C, Szalkowski D, Bergeron R, Doebber T, Zhang BB (2005) Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest 115(4):1030\u20131038. doi: 10.1172\/JCI23962","journal-title":"J Clin Invest"},{"issue":"7\u20138","key":"278_CR22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/ars.2005.7.1053","volume":"7","author":"GD Frank","year":"2005","unstructured":"Frank GD, Eguchi S, Motley ED (2005) The role of reactive oxygen species in insulin signaling in the vasculature. Antioxid Redox Signal 7(7\u20138):1053\u20131061","journal-title":"Antioxid Redox Signal"},{"issue":"85","key":"278_CR23","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3(85):85ra46. doi: 10.1126\/scitranslmed.3002231","journal-title":"Sci Transl Med"},{"issue":"1","key":"278_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361(1):11\u201321. doi: 10.1056\/NEJMoa0810457","journal-title":"N Engl J Med"},{"issue":"3","key":"278_CR25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1681\/ASN.2008070694","volume":"20","author":"B Schermer","year":"2009","unstructured":"Schermer B, Benzing T (2009) Lipid-protein interactions along the slit diaphragm of podocytes. J Am Soc Nephrol 20(3):473\u2013478","journal-title":"J Am Soc Nephrol"},{"key":"278_CR26","doi-asserted-by":"crossref","first-page":"653182","DOI":"10.4061\/2011\/653182","volume":"2011","author":"M Tesauro","year":"2011","unstructured":"Tesauro M, Canale MP, Rodia G, Di Daniele N, Lauro D, Scuteri A, Cardillo C (2011) Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract 2011:653182","journal-title":"Cardiol Res Pract"},{"issue":"5","key":"278_CR27","first-page":"1645","volume":"118","author":"K Sharma","year":"2008","unstructured":"Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118(5):1645\u20131656","journal-title":"J Clin Invest"},{"issue":"11","key":"278_CR28","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1093\/ndt\/gfp302","volume":"24","author":"R Lennon","year":"2009","unstructured":"Lennon R, Pons D, Sabin MA, Wei C, Shield JP, Coward RJ, Tavare JM, Mathieson PW, Saleem MA, Welsh GI (2009) Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. Nephrol Dial Transpl 24(11):3288\u20133296","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"278_CR29","doi-asserted-by":"publisher","first-page":"e0142291","DOI":"10.1371\/journal.pone.0142291","volume":"10","author":"C Martinez-Garcia","year":"2015","unstructured":"Martinez-Garcia C, Izquierdo-Lahuerta A, Vivas Y, Velasco I, Yeo TK, Chen S, Medina-Gomez G (2015) Renal lipotoxicity-associated inflammation and insulin resistance affects actin cytoskeleton organization in podocytes. PLoS One 10(11):e0142291. doi: 10.1371\/journal.pone.0142291 (PONE-D-15-26733 [pii])","journal-title":"PLoS One"},{"issue":"4","key":"278_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2010.08.015","volume":"12","author":"GI Welsh","year":"2010","unstructured":"Welsh GI, Hale LJ, Eremina V, Jeansson M, Maezawa Y, Lennon R, Pons DA, Owen RJ, Satchell SC, Miles MJ, Caunt CJ, McArdle CA, Pavenstadt H, Tavare JM, Herzenberg AM, Kahn CR, Mathieson PW, Quaggin SE, Saleem MA, Coward RJ (2010) Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab 12(4):329\u2013340","journal-title":"Cell Metab"},{"issue":"4","key":"278_CR31","doi-asserted-by":"publisher","first-page":"F821","DOI":"10.1152\/ajprenal.00196.2010","volume":"299","author":"J Sieber","year":"2010","unstructured":"Sieber J, Lindenmeyer MT, Kampe K, Campbell KN, Cohen CD, Hopfer H, Mundel P, Jehle AW (2010) Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am J Physiol Renal Physiol 299(4):F821\u2013F829. doi: 10.1152\/ajprenal.00196.2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"278_CR32","doi-asserted-by":"publisher","first-page":"F401","DOI":"10.1152\/ajprenal.00454.2013","volume":"306","author":"K Kampe","year":"2014","unstructured":"Kampe K, Sieber J, Orellana JM, Mundel P, Jehle AW (2014) Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2. Am J Physiol Renal Physiol 306(4):F401\u2013F409. doi: 10.1152\/ajprenal.00454.2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"278_CR33","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.freeradbiomed.2010.03.021","volume":"48","author":"E Katsoulieris","year":"2010","unstructured":"Katsoulieris E, Mabley JG, Samai M, Sharpe MA, Green IC, Chatterjee PK (2010) Lipotoxicity in renal proximal tubular cells: relationship between endoplasmic reticulum stress and oxidative stress pathways. Free Radic Biol Med 48(12):1654\u20131662","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"278_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mce.2010.07.016","volume":"328","author":"ME Hyvonen","year":"2010","unstructured":"Hyvonen ME, Saurus P, Wasik A, Heikkila E, Havana M, Trokovic R, Saleem M, Holthofer H, Lehtonen S (2010) Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes. Mol Cell Endocrinol 328(1\u20132):70\u201379. doi: 10.1016\/j.mce.2010.07.016","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"278_CR35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/art.1780290412","volume":"29","author":"DR Robinson","year":"1986","unstructured":"Robinson DR, Prickett JD, Makoul GT, Steinberg AD, Colvin RB (1986) Dietary fish oil reduces progression of established renal disease in (NZB x NZW)F1 mice and delays renal disease in BXSB and MRL\/1 strains. Arthritis Rheum 29(4):539\u2013546","journal-title":"Arthritis Rheum"},{"issue":"4","key":"278_CR36","doi-asserted-by":"crossref","first-page":"F895","DOI":"10.1152\/ajprenal.00217.2009","volume":"297","author":"WS An","year":"2009","unstructured":"An WS, Kim HJ, Cho KH, Vaziri ND (2009) Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol 297(4):F895\u2013F903","journal-title":"Am J Physiol Renal Physiol"},{"issue":"19","key":"278_CR37","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.1074\/jbc.M609701200","volume":"282","author":"HY Liu","year":"2007","unstructured":"Liu HY, Collins QF, Xiong Y, Moukdar F, Lupo EG Jr, Liu Z, Cao W (2007) Prolonged treatment of primary hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase. J Biol Chem 282(19):14205\u201314212. doi: 10.1074\/jbc.M609701200","journal-title":"J Biol Chem"},{"issue":"4","key":"278_CR38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12263-012-0295-5","volume":"7","author":"C Tovar-Palacio","year":"2012","unstructured":"Tovar-Palacio C, Torres N, Diaz-Villasenor A, Tovar AR (2012) The role of nuclear receptors in the kidney in obesity and metabolic syndrome. Genes Nutr 7(4):483\u2013498. doi: 10.1007\/s12263-012-0295-5","journal-title":"Genes Nutr"},{"issue":"4","key":"278_CR39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.2004090742","volume":"16","author":"B Becker","year":"2005","unstructured":"Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D (2005) Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 16(4):1091\u20131098","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"278_CR40","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bbrc.2010.03.043","volume":"394","author":"X Hou","year":"2010","unstructured":"Hou X, Shen YH, Li C, Wang F, Zhang C, Bu P, Zhang Y (2010) PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity. Biochem Biophys Res Commun 394(3):653\u2013659. doi: 10.1016\/j.bbrc.2010.03.043","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"278_CR41","first-page":"39","volume":"55","author":"J Lipscombe","year":"2001","unstructured":"Lipscombe J, Lewis GF, Cattran D, Bargman JM (2001) Deterioration in renal function associated with fibrate therapy. Clin Nephrol 55(1):39\u201344","journal-title":"Clin Nephrol"},{"issue":"4","key":"278_CR42","doi-asserted-by":"crossref","first-page":"c230","DOI":"10.1159\/000224789","volume":"112","author":"Z Mao","year":"2009","unstructured":"Mao Z, Ong AC (2009) Peroxisome proliferator-activated receptor gamma agonists in kidney disease\u2014future promise, present fears. Nephron Clin Pract 112(4):c230\u2013c241","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"278_CR43","doi-asserted-by":"publisher","first-page":"F639","DOI":"10.1152\/ajprenal.00189.2001","volume":"282","author":"F Zheng","year":"2002","unstructured":"Zheng F, Fornoni A, Elliot SJ, Guan Y, Breyer MD, Striker LJ, Striker GE (2002) Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation. Am J Physiol Renal Physiol 282(4):F639\u2013F648. doi: 10.1152\/ajprenal.00189.2001","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"278_CR44","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/sj.ki.5002248","volume":"71","author":"T Kanjanabuch","year":"2007","unstructured":"Kanjanabuch T, Ma LJ, Chen J, Pozzi A, Guan Y, Mundel P, Fogo AB (2007) PPAR-gamma agonist protects podocytes from injury. Kidney Int 71(12):1232\u20131239. doi: 10.1038\/sj.ki.5002248","journal-title":"Kidney Int"},{"issue":"10","key":"278_CR45","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1053\/meta.2001.26703","volume":"50","author":"T Nakamura","year":"2001","unstructured":"Nakamura T, Ushiyama C, Osada S, Hara M, Shimada N, Koide H (2001) Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism 50(10):1193\u20131196. doi: 10.1053\/meta.2001.26703","journal-title":"Metabolism"},{"issue":"1","key":"278_CR46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.HYP.0000103629.01745.59","volume":"43","author":"AD Dobrian","year":"2004","unstructured":"Dobrian AD, Schriver SD, Khraibi AA, Prewitt RL (2004) Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension 43(1):48\u201356","journal-title":"Hypertension"},{"issue":"1","key":"278_CR47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.vph.2006.01.017","volume":"45","author":"AD Dobrian","year":"2006","unstructured":"Dobrian AD (2006) The complex role of PPARgamma in renal dysfunction in obesity: managing a Janus-faced receptor. Vascul Pharmacol 45(1):36\u201345. doi: 10.1016\/j.vph.2006.01.017","journal-title":"Vascul Pharmacol"},{"issue":"6","key":"278_CR48","first-page":"522","volume":"5","author":"Y Chen","year":"2012","unstructured":"Chen Y, Luo Q, Xiong Z, Liang W, Chen L, Xiong Z (2012) Telmisartan counteracts TGF-beta1 induced epithelial-to-mesenchymal transition via PPAR-gamma in human proximal tubule epithelial cells. Int J Clin Exp Pathol 5(6):522\u2013529","journal-title":"Int J Clin Exp Pathol"},{"key":"278_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.phrs.2014.06.011","volume":"88","author":"TI Kassimatis","year":"2014","unstructured":"Kassimatis TI, Goldsmith DJ (2014) Statins in chronic kidney disease and kidney transplantation. Pharmacol Res 88:62\u201373. doi: 10.1016\/j.phrs.2014.06.011 (S1043-6618(14)00103-0 [pii])","journal-title":"Pharmacol Res"},{"issue":"5","key":"278_CR50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1185\/03007995.2013.779237","volume":"29","author":"D Nikolic","year":"2013","unstructured":"Nikolic D, Nikfar S, Salari P, Rizzo M, Ray KK, Pencina MJ, Mikhailidis DP, Toth PP, Nicholls SJ, Rysz J, Abdollahi M, Banach M, Lipid Blood Pressure, Meta-Analysis Collaboration G (2013) Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. Curr Med Res Opin 29(5):435\u2013451. doi: 10.1185\/03007995.2013.779237","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"278_CR51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000330355","volume":"34","author":"RG Kalaitzidis","year":"2011","unstructured":"Kalaitzidis RG, Elisaf MS (2011) The role of statins in chronic kidney disease. Am J Nephrol 34(3):195\u2013202","journal-title":"Am J Nephrol"},{"issue":"6","key":"278_CR52","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ki.2014.31","volume":"85","author":"C Wanner","year":"2014","unstructured":"Wanner C, Tonelli M, Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group M (2014) KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int 85(6):1303\u20131309. doi: 10.1038\/ki.2014.31","journal-title":"Kidney Int"},{"issue":"2","key":"278_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrneph.2013.272","volume":"10","author":"MH Muskiet","year":"2014","unstructured":"Muskiet MH, Smits MM, Morsink LM, Diamant M (2014) The gut-renal axis: do incretin-based agents confer renoprotection in diabetes? Nat Rev Nephrol 10(2):88\u2013103. doi: 10.1038\/nrneph.2013.272","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"278_CR54","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1681\/ASN.2005050485","volume":"16","author":"G Tuffin","year":"2005","unstructured":"Tuffin G, Waelti E, Huwyler J, Hammer C, Marti HP (2005) Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney. J Am Soc Nephrol 16(11):3295\u20133305. doi: 10.1681\/ASN.2005050485","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"278_CR55","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1002\/art.24026","volume":"58","author":"Y Scindia","year":"2008","unstructured":"Scindia Y, Deshmukh U, Thimmalapura PR, Bagavant H (2008) Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus. Arthritis Rheum 58(12):3884\u20133891. doi: 10.1002\/art.24026","journal-title":"Arthritis Rheum"},{"issue":"2","key":"278_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jconrel.2009.09.008","volume":"141","author":"SA Asgeirsdottir","year":"2010","unstructured":"Asgeirsdottir SA, Talman EG, de Graaf IA, Kamps JA, Satchell SC, Mathieson PW, Ruiters MH, Molema G (2010) Targeted transfection increases siRNA uptake and gene silencing of primary endothelial cells in vitro\u2013a quantitative study. J Control Release 141(2):241\u2013251. doi: 10.1016\/j.jconrel.2009.09.008","journal-title":"J Control Release"},{"issue":"1","key":"278_CR57","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1152\/ajpendo.00587.2005","volume":"291","author":"CR Bruce","year":"2006","unstructured":"Bruce CR, Thrush AB, Mertz VA, Bezaire V, Chabowski A, Heigenhauser GJ, Dyck DJ (2006) Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291(1):E99\u2013E107","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"14","key":"278_CR58","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.addr.2010.08.012","volume":"62","author":"JW Leeuwis","year":"2010","unstructured":"Leeuwis JW, Nguyen TQ, Dendooven A, Kok RJ, Goldschmeding R (2010) Targeting podocyte-associated diseases. Adv Drug Deliv Rev 62(14):1325\u20131336. doi: 10.1016\/j.addr.2010.08.012","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"278_CR59","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrneph.2013.274","volume":"10","author":"J Reiser","year":"2014","unstructured":"Reiser J, Sever S, Faul C (2014) Signal transduction in podocytes-spotlight on receptor tyrosine kinases. Nat Rev Nephrol 10(2):104\u2013115. doi: 10.1038\/nrneph.2013.274","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"278_CR60","doi-asserted-by":"publisher","first-page":"e77468","DOI":"10.1371\/journal.pone.0077468","volume":"8","author":"ML Alvarez","year":"2013","unstructured":"Alvarez ML, Khosroheidari M, Eddy E, Kiefer J (2013) Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy. PLoS One 8(10):e77468. doi: 10.1371\/journal.pone.0077468","journal-title":"PLoS One"},{"issue":"2","key":"278_CR61","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajpath.2013.10.007","volume":"184","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Chung AC, Huang XR, Dong Y, Yu X, Lan HY (2014) Identification of novel long noncoding RNAs associated with TGF-beta\/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am J Pathol 184(2):409\u2013417. doi: 10.1016\/j.ajpath.2013.10.007","journal-title":"Am J Pathol"},{"issue":"1","key":"278_CR62","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrneph.2014.202","volume":"11","author":"P Trionfini","year":"2015","unstructured":"Trionfini P, Benigni A, Remuzzi G (2015) MicroRNAs in kidney physiology and disease. Nat Rev Nephrol 11(1):23\u201333. doi: 10.1038\/nrneph.2014.202 (nrneph.2014.202 [pii])","journal-title":"Nat Rev Nephrol"},{"key":"278_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1755-1536-7-12","volume":"7","author":"SP Srivastava","year":"2014","unstructured":"Srivastava SP, Shi S, Koya D, Kanasaki K (2014) Lipid mediators in diabetic nephropathy. Fibrogenesis Tissue Repair 7:12. doi: 10.1186\/1755-1536-7-12 (1755-1536-7-12 [pii])","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"11","key":"278_CR64","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.2337\/db10-0019","volume":"59","author":"XX Wang","year":"2010","unstructured":"Wang XX, Jiang T, Shen Y, Caldas Y, Miyazaki-Anzai S, Santamaria H, Urbanek C, Solis N, Scherzer P, Lewis L, Gonzalez FJ, Adorini L, Pruzanski M, Kopp JB, Verlander JW, Levi M (2010) Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes 59(11):2916\u20132927. doi: 10.2337\/db10-0019 (db10-0019 [pii])","journal-title":"Diabetes"},{"issue":"10","key":"278_CR65","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.2337\/db06-1642","volume":"56","author":"T Jiang","year":"2007","unstructured":"Jiang T, Wang XX, Scherzer P, Wilson P, Tallman J, Takahashi H, Li J, Iwahashi M, Sutherland E, Arend L, Levi M (2007) Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes 56(10):2485\u20132493. doi: 10.2337\/db06-1642 (db06-1642 [pii])","journal-title":"Diabetes"},{"key":"278_CR66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","volume":"81","author":"JL Rinn","year":"2012","unstructured":"Rinn JL, Chang HY (2012) Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145\u2013166. doi: 10.1146\/annurev-biochem-051410-092902","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"278_CR67","doi-asserted-by":"publisher","first-page":"e18671","DOI":"10.1371\/journal.pone.0018671","volume":"6","author":"ML Alvarez","year":"2011","unstructured":"Alvarez ML, DiStefano JK (2011) Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy. PLoS One 6(4):e18671. doi: 10.1371\/journal.pone.0018671","journal-title":"PLoS One"},{"issue":"1","key":"278_CR68","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.celrep.2013.12.015","volume":"6","author":"P Halley","year":"2014","unstructured":"Halley P, Kadakkuzha BM, Faghihi MA, Magistri M, Zeier Z, Khorkova O, Coito C, Hsiao J, Lawrence M, Wahlestedt C (2014) Regulation of the apolipoprotein gene cluster by a long noncoding RNA. Cell Rep 6(1):222\u2013230. doi: 10.1016\/j.celrep.2013.12.015 (S2211-1247(13)00760-2 [pii])","journal-title":"Cell Rep"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0278-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-016-0278-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0278-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0278-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:58:24Z","timestamp":1777564704000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/29\/5\/603\/8373363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1007\/s40620-016-0278-5","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]}}}